1.18
-0.06(-4.84%)
Currency In USD
| Previous Close | 1.24 |
| Open | 1.21 |
| Day High | 1.21 |
| Day Low | 1.15 |
| 52-Week High | 1.99 |
| 52-Week Low | 0.76 |
| Volume | 15,207 |
| Average Volume | 51,780 |
| Market Cap | 44.6M |
| PE | -1.79 |
| EPS | -0.66 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 1.3 |
| Change | -0.06 |
If you invested $1000 in Apyx Medical Corporation (APYX) since IPO date, it would be worth $182.38 as of May 09, 2025 at a share price of $1.18. Whereas If you bought $1000 worth of Apyx Medical Corporation (APYX) shares 5 years ago, it would be worth $323.29 as of May 09, 2025 at a share price of $1.18.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
Two studies report favorable clinical outcomes and safety data for Renuvion® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin Rapid weight loss due to GLP-1 drugs expected to drive growth in patients
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 12:45 PM GMT
CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announ
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
GlobeNewswire Inc.
Feb 27, 2025 1:00 PM GMT
CLEARWATER, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announ